123 related articles for article (PubMed ID: 16487228)
1. Low incidence of hypertensive disorders of pregnancy in women treated with spiramycin for toxoplasma infection.
Todros T; Verdiglione P; Oggè G; Paladini D; Vergani P; Cardaropoli S
Br J Clin Pharmacol; 2006 Mar; 61(3):336-40. PubMed ID: 16487228
[TBL] [Abstract][Full Text] [Related]
2. [Clinical experience on treating Toxoplasma gondii infection during pregnancy by using acetyl spiramycin combined with azithromycin].
Tang HX; Xiong XF; Qin ZQ
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2013 Oct; 25(5):555-6. PubMed ID: 24490384
[TBL] [Abstract][Full Text] [Related]
3. Role of spiramycin in prevention of fetal toxoplasmosis.
Avci ME; Arslan F; Çiftçi Ş; Ekiz A; Tüten A; Yildirim G; Madazli R
J Matern Fetal Neonatal Med; 2016; 29(13):2073-6. PubMed ID: 26365472
[TBL] [Abstract][Full Text] [Related]
4. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis.
Daffos F; Forestier F; Capella-Pavlovsky M; Thulliez P; Aufrant C; Valenti D; Cox WL
N Engl J Med; 1988 Feb; 318(5):271-5. PubMed ID: 3336419
[TBL] [Abstract][Full Text] [Related]
5. [Prevention of congenital toxoplasmosis].
Russo M; Galanti B
Clin Ter; 1990 Sep; 134(6):383-92. PubMed ID: 2149535
[TBL] [Abstract][Full Text] [Related]
6. Toxoplasmosis in pregnancy is still an open subject.
Greco P; Vimercati A; Angelici MC; Carbonara S; Doria G; Nappi L; Angarano G; Selvaggi L
J Perinat Med; 2003; 31(1):36-40. PubMed ID: 12661142
[TBL] [Abstract][Full Text] [Related]
7. Post-treatment assessment of acute Toxoplasma infection during pregnancy.
Habib FA
J Obstet Gynaecol; 2008 Aug; 28(6):593-5. PubMed ID: 19003652
[TBL] [Abstract][Full Text] [Related]
8. Azithromycin inhibits vertical transmission of Toxoplasma gondii in Calomys callosus (Rodentia: Cricetidae).
Costa IN; Angeloni MB; Santana LA; Barbosa BF; Silva MC; Rodrigues AA; Rostkowsa C; Magalhães PM; Pena JD; Silva DA; Mineo JR; Ferro EA
Placenta; 2009 Oct; 30(10):884-90. PubMed ID: 19703714
[TBL] [Abstract][Full Text] [Related]
9. Toxoplasmosis during pregnancy.
Many A; Koren G
Can Fam Physician; 2006 Jan; 52(1):29-30, 32. PubMed ID: 16477906
[TBL] [Abstract][Full Text] [Related]
10. Management of Toxoplasma gondii infection during pregnancy.
Montoya JG; Remington JS
Clin Infect Dis; 2008 Aug; 47(4):554-66. PubMed ID: 18624630
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of rapid treatment initiation following primary Toxoplasma gondii infection during pregnancy.
Hotop A; Hlobil H; Gross U
Clin Infect Dis; 2012 Jun; 54(11):1545-52. PubMed ID: 22460980
[TBL] [Abstract][Full Text] [Related]
12. Determination of insulin resistance using the homeostatic model assessment (HOMA) and its relation with the risk of developing pregnancy-induced hypertension.
Sierra-Laguado J; García RG; Celedón J; Arenas-Mantilla M; Pradilla LP; Camacho PA; López-Jaramillo P
Am J Hypertens; 2007 Apr; 20(4):437-42. PubMed ID: 17386353
[TBL] [Abstract][Full Text] [Related]
13. [Toxoplasma infections in early pregnancy: consequences and management].
Wallon M; Gaucherand P; Al Kurdi M; Peyron F
J Gynecol Obstet Biol Reprod (Paris); 2002 Sep; 31(5):478-84. PubMed ID: 12379832
[TBL] [Abstract][Full Text] [Related]
14. Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa.
Molvi SN; Mir S; Rana VS; Jabeen F; Malik AR
Arch Gynecol Obstet; 2012 Jun; 285(6):1553-62. PubMed ID: 22249781
[TBL] [Abstract][Full Text] [Related]
15. Toxoplasmosis in pregnant women in Crete.
Antoniou M; Tzouvali H; Sifakis S; Galanakis E; Georgopoulou E; Tselentis Y
Parassitologia; 2007 Dec; 49(4):231-3. PubMed ID: 18689233
[TBL] [Abstract][Full Text] [Related]
16. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii.
Gilbert R; Gras L;
BJOG; 2003 Feb; 110(2):112-20. PubMed ID: 12618153
[TBL] [Abstract][Full Text] [Related]
17. Successful tolerance induction to spiramycin in pregnancy.
Nucera E; Roncallo C; Masini L; Buonomo A; De Pasquale T; Pollastrini E; Schiavino D; Patriarca G
Scand J Infect Dis; 2002; 34(7):550-1. PubMed ID: 12195890
[TBL] [Abstract][Full Text] [Related]
18. [Fetomaternal therapeutic follow-up of spiramycin during pregnancy].
Forestier F; Daffos F; Rainaut M; Desnottes JF; Gaschard JC
Arch Fr Pediatr; 1987; 44(7):539-44. PubMed ID: 3426376
[TBL] [Abstract][Full Text] [Related]
19. Reliability of immunoglobulin G antitoxoplasma avidity test and effects of treatment on avidity indexes of infants and pregnant women.
Flori P; Tardy L; Patural H; Bellete B; Varlet MN; Hafid J; Raberin H; Sung RT
Clin Diagn Lab Immunol; 2004 Jul; 11(4):669-74. PubMed ID: 15242939
[TBL] [Abstract][Full Text] [Related]
20. Role of spiramycin/cotrimoxazole association in the mother-to-child transmission of toxoplasmosis infection in pregnancy.
Valentini P; Annunziata ML; Angelone DF; Masini L; De Santis M; Testa A; Grillo RL; Speziale D; Ranno O
Eur J Clin Microbiol Infect Dis; 2009 Mar; 28(3):297-300. PubMed ID: 18716804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
